Vertex and Obsidian partner to discover gene-editing medicines

Vertex Pharmaceuticals and Obsidian Therapeutics collaborate to discover new treatments that regulate gene editing. Credit: Illustration by Jill George using images from the National Human Genome Research Institute & the National Institute of Allergy and Infectious Diseases.